Summary of Key Points Core Viewpoint - 康臣药业 has been actively repurchasing its shares, indicating a strategy to support its stock price amidst recent declines [1][2]. Group 1: Share Buyback Activity - On December 12, 康臣药业 repurchased 231,000 shares at a price range of HKD 14.760 to HKD 14.970, totaling HKD 3.4373 million [1]. - The stock closed at HKD 14.870 on the same day, reflecting a decrease of 0.87%, with total trading volume of HKD 17.2563 million [1]. - Since December 10, the company has conducted buybacks for three consecutive days, accumulating a total of 726,000 shares and a total expenditure of HKD 10.8264 million, during which the stock price fell by 0.93% [1]. Group 2: Year-to-Date Buyback Summary - Year-to-date, 康臣药业 has executed 55 buyback transactions, acquiring a total of 13.182 million shares for a cumulative amount of HKD 178 million [2]. - The detailed buyback data shows various transactions with the highest buyback price reaching HKD 15.840 and the lowest at HKD 11.000 [3].
康臣药业(01681.HK)连续3日回购，累计回购72.60万股